Pourab Roy

Pourab Roy

National Center for Toxicological Research - Jefferson / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 5462651
-
person_outline Pourab Roy's MOST POPULAR ARTICLES
1-) FDA approval summary: capmatinib and tepotinib for the treatment of metastatic NSCLC harboring MET exon 14 skipping mutations or alterations Clinical Cancer Research 28 (2), 249-254, 2022
2-) Updated safety and efficacy of REGN5458, a BCMAxCD3 bispecific antibody, treatment for relapsed/refractory multiple myeloma: a phase 1/2 first-in-human study Blood 140 (Supplement 1), 10140-10141, 2022
3-) Response of single leukemic cells to peptidase inhibitor therapy across time and dose using a microfluidic device Integrative Biology 6 (2), 164-174, 2014
4-) Exploration of baseline patient-reported side effect bother from cancer therapy Clinical Trials 17 (3), 332-337, 2020
5-) FDA analysis of ECOG performance status and safety outcomes. Journal of clinical oncology 38 (15_suppl), 12024-12024, 2020